Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma of Skin AJCC V6”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05767879
What this trial is testing

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

Who this might be right for
Melanoma Stage IIIIn-Transit Metastasis of Cutaneous Melanoma
Leiden University Medical Center 28
Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Testing effectiveness (Phase 2)UnknownNCT02142335
What this trial is testing

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

Who this might be right for
Malignant Melanoma of Skin Stage IIIMetastatic Melanoma
California Cancer Assocaties for Research & Excellence 17
Not applicableStudy completedNCT02794636
What this trial is testing

Interferon Toxicities in Melanoma Treatment

Who this might be right for
Stage III Melanoma
Bristol-Myers Squibb 436
Very early researchStudy completedNCT00962845
What this trial is testing

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Rutgers, The State University of New Jersey 20
Testing effectiveness (Phase 2)Study completedNCT00081042
What this trial is testing

ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00398073
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00007969
What this trial is testing

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
QLT Inc.
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT05361174
What this trial is testing

Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Who this might be right for
Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more
Iovance Biotherapeutics, Inc. 53
Not applicableLooking for participantsNCT07049276
What this trial is testing

The Multicentre Selective Lymphadenectomy Trial - 3

Who this might be right for
Cutaneous Melanoma, Stage III
Melanoma Institute Australia 1,500
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Not applicableActive Not RecruitingNCT04990726
What this trial is testing

Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+5 more
M.D. Anderson Cancer Center 126
Testing effectiveness (Phase 2)UnknownNCT01676649
What this trial is testing

Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

Who this might be right for
Untreated Stage III Melanoma or Stage IV Melanoma
Jewish General Hospital 30
Early research (Phase 1)UnknownNCT03353402
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy

Who this might be right for
Melanoma Stage IvUnresectable Stage III Melanoma
Sheba Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00436605
What this trial is testing

Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
National Cancer Institute (NCI) 39
Early research (Phase 1)UnknownNCT00037037
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04139902
What this trial is testing

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Diwakar Davar 48
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)WithdrawnNCT01851408
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI)
Next Page